- Home
- INO vs FBIOP Comparison
INO vs FBIOP Comparison
Compare INO & FBIOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INO
- FBIOP
- Stock Information
- Founded
- INO 1979
- FBIOP N/A
- Country
- INO United States
- FBIOP United States
- Employees
- INO N/A
- FBIOP 101
- Industry
- INO Medical/Dental Instruments
- FBIOP Biotechnology: Pharmaceutical Preparations
- Sector
- INO Health Care
- FBIOP Health Care
- Exchange
- INO Nasdaq
- FBIOP Nasdaq
- Market Cap
- INO N/A
- FBIOP N/A
- IPO Year
- INO 1998
- FBIOP N/A
- Fundamental
- Price
- INO $1.82
- FBIOP $6.15
- Analyst Decision
- INO Buy
- FBIOP
- Analyst Count
- INO 5
- FBIOP 0
- Target Price
- INO $12.20
- FBIOP N/A
- AVG Volume (30 Days)
- INO 465.2K
- FBIOP N/A
- Earning Date
- INO 05-13-2025
- FBIOP N/A
- Dividend Yield
- INO N/A
- FBIOP N/A
- EPS Growth
- INO N/A
- FBIOP N/A
- EPS
- INO N/A
- FBIOP N/A
- Revenue
- INO $217,756.00
- FBIOP N/A
- Revenue This Year
- INO $1,308.92
- FBIOP N/A
- Revenue Next Year
- INO $611.08
- FBIOP N/A
- P/E Ratio
- INO N/A
- FBIOP N/A
- Revenue Growth
- INO N/A
- FBIOP N/A
- 52 Week Low
- INO $1.42
- FBIOP N/A
- 52 Week High
- INO $13.44
- FBIOP N/A
- Technical
- Relative Strength Index (RSI)
- INO 50.36
- FBIOP 47.56
- Support Level
- INO $1.69
- FBIOP $6.36
- Resistance Level
- INO $1.95
- FBIOP $6.80
- Average True Range (ATR)
- INO 0.10
- FBIOP 0.37
- MACD
- INO -0.00
- FBIOP 0.01
- Stochastic Oscillator
- INO 50.00
- FBIOP 45.52
About FBIOP Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.